SeraLab Overview
- Founded
-
1998
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
SeraLab General Information
Description
Developer of biologically manufactured components for drug development. The company controls and develops disease state matrices manufactured from human and animal blood, plasma and serum, used in drug discovery, compound development and clinical and research diagnostics, enabling scientists and biomedical researchers to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes.
Contact Information
Primary Industry
Distributors/Wholesale
Other Industries
Drug Discovery
Biotechnology
Acquirer
Primary Office
- 209, Tower Bridge Business Centre
- 46-48 East Smithfield
- London E1W 1AW
- England, United Kingdom
SeraLab Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|